186 related articles for article (PubMed ID: 17985258)
1. Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS).
Krasenbrink I; Fühlhuber V; Juhasz-Boess I; Stolz E; Hahn A; Kaps M; Hero B; Blaes F
Neuropediatrics; 2007 Jun; 38(3):114-6. PubMed ID: 17985258
[TBL] [Abstract][Full Text] [Related]
2. Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome.
Korfei M; Fühlhuber V; Schmidt-Wöll T; Kaps M; Preissner KT; Blaes F
J Neuroimmunol; 2005 Dec; 170(1-2):150-7. PubMed ID: 16203043
[TBL] [Abstract][Full Text] [Related]
3. IgG subclass distribution of autoantibodies in pediatric opsoclonus-myoclonus syndrome.
Beck S; Fühlhuber V; Krasenbrink I; Tschernatsch M; Kneifel N; Kirsten A; Jaeger C; Kaps M; Preissner KT; Lang B; Rostasy K; Blaes F
J Neuroimmunol; 2007 Apr; 185(1-2):145-9. PubMed ID: 17324472
[TBL] [Abstract][Full Text] [Related]
4. High dose pulsatile dexamethasone therapy in children with opsoclonus-myoclonus syndrome.
Rostásy K; Wilken B; Baumann M; Müller-Deile K; Bieber I; Gärtner J; Möller P; Angelini P; Hero B
Neuropediatrics; 2006 Oct; 37(5):291-5. PubMed ID: 17236108
[TBL] [Abstract][Full Text] [Related]
5. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome.
Blaes F; Fühlhuber V; Korfei M; Tschernatsch M; Behnisch W; Rostasy K; Hero B; Kaps M; Preissner KT
Ann Neurol; 2005 Aug; 58(2):313-7. PubMed ID: 15988749
[TBL] [Abstract][Full Text] [Related]
6. Opsoclonus-myoclonus syndrome: a clinicopathological confrontation.
Baets J; Pals P; Bergmans B; Foncke E; Smets K; Hauman H; Vanderwegen L; Cras P
Acta Neurol Belg; 2006 Sep; 106(3):142-6. PubMed ID: 17091618
[TBL] [Abstract][Full Text] [Related]
7. Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.
Burke MJ; Cohn SL
Pediatr Blood Cancer; 2008 Mar; 50(3):679-80. PubMed ID: 16900484
[TBL] [Abstract][Full Text] [Related]
8. Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses.
Ertle F; Behnisch W; Al Mulla NA; Bessisso M; Rating D; Mechtersheimer G; Hero B; Kulozik AE
Pediatr Blood Cancer; 2008 Mar; 50(3):683-7. PubMed ID: 17226843
[TBL] [Abstract][Full Text] [Related]
9. Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome.
Tate ED; Allison TJ; Pranzatelli MR; Verhulst SJ
J Pediatr Oncol Nurs; 2005; 22(1):8-19. PubMed ID: 15574722
[TBL] [Abstract][Full Text] [Related]
10. Response to rituximab in a child with neuroblastoma and opsoclonus-myoclonus.
Bell J; Moran C; Blatt J
Pediatr Blood Cancer; 2008 Feb; 50(2):370-1. PubMed ID: 16652344
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of autoantibodies in Thai elderly.
Hanvivatvong O; Tirawatnapong S; Kaowopas Y; Jitapankul S
J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S242-9. PubMed ID: 12929996
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of autoantibodies in Saudi population.
Baig MM; Shere SJ
J Med; 1989; 20(3-4):286-90. PubMed ID: 2809425
[TBL] [Abstract][Full Text] [Related]
13. Neuroblastoma found in a 4-year-old after rituximab therapy for opsoclonus-myoclonus.
Chang BH; Koch T; Hopkins K; Malempati S
Pediatr Neurol; 2006 Sep; 35(3):213-5. PubMed ID: 16939863
[TBL] [Abstract][Full Text] [Related]
14. Immunologic and clinical responses to rituximab in a child with opsoclonus-myoclonus syndrome.
Pranzatelli MR; Tate ED; Travelstead AL; Longee D
Pediatrics; 2005 Jan; 115(1):e115-9. PubMed ID: 15601813
[TBL] [Abstract][Full Text] [Related]
15. Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004.
Matthay KK; Blaes F; Hero B; Plantaz D; De Alarcon P; Mitchell WG; Pike M; Pistoia V
Cancer Lett; 2005 Oct; 228(1-2):275-82. PubMed ID: 15922508
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic myoclonus.
Borg M
Neurophysiol Clin; 2006; 36(5-6):309-18. PubMed ID: 17336775
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic opsoclonus myoclonus syndrome associated with inflammatory myofibroblastic tumor in a pediatric patient.
Gerstle K; Siddiqui A; Schulte JJ; Cohn SL
Pediatr Blood Cancer; 2020 Aug; 67(8):e28218. PubMed ID: 32472953
[TBL] [Abstract][Full Text] [Related]
18. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.
Cooper R; Khakoo Y; Matthay KK; Lukens JN; Seeger RC; Stram DO; Gerbing RB; Nakagawa A; Shimada H
Med Pediatr Oncol; 2001 Jun; 36(6):623-9. PubMed ID: 11344493
[TBL] [Abstract][Full Text] [Related]
19. [The opsoclonus-myoclonus syndrome].
de Brabander C; Hoff JI; Tijssen CC; Lammers GJ; Verschuuren JJ
Ned Tijdschr Geneeskd; 2005 Jan; 149(4):201-4. PubMed ID: 15702740
[TBL] [Abstract][Full Text] [Related]
20. An update on opsoclonus.
Wong A
Curr Opin Neurol; 2007 Feb; 20(1):25-31. PubMed ID: 17215685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
